Advertisement
Advertisement
HIND
Vyome Holdings, Inc. Common Stock
2.25
USDSponsored
+0.04
+1.81%
Aug 11, 12:30 UTC -4
Open
HIND Earnings Reports
Positive Surprise Ratio
HIND beat 11 of 31 last estimates.
35%
Next Report
Tomorrow
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.19
Implied change from Q1 26 (Revenue/ EPS)
-100.00%
/+26.67%
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Vyome Holdings, Inc. Common Stock earnings per share and revenue
On May 12, 2026, HIND reported earnings of -0.15 USD per share (EPS) for Q1 26, beating the estimate of -0.18 USD, resulting in a 18.30% surprise. Revenue reached 31.59 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a -3.03% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.19 USD, with revenue projected to reach -- USD, implying an increase of 26.67% EPS, and decrease of -100.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Actinium Pharmaceuticals, Inc
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.22
Actual
$0.89
Surprise
+502.71%
Kiora Pharmaceuticals, Inc. Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.63
Actual
-$0.34
Surprise
+46.24%
AIM ImmunoTech Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.17
Actual
-$0.43
Surprise
-150.44%
Oruka Therapeutics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.52
Actual
-$0.55
Surprise
-4.62%
Amylyx Pharmaceuticals, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.36
Actual
-$0.39
Surprise
-5.95%
Harrow, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.18
Actual
-$0.34
Surprise
-85.19%
Silence Therapeutics Plc - ADR
Report Date
Aug 10, 2026 For Q2 26
Estimate
-Actual
-$0.26
Surprise
-
Minerva Neurosciences, Inc
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.17
Surprise
-44.93%
Tonix Pharmaceuticals Holding Corp.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$2.75
Actual
-$2.44
Surprise
+11.29%
Fractyl Health, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+12.85%
FAQ
What were Vyome Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Vyome Holdings, Inc. Common Stock reported EPS of -$0.15, beating estimates by 18.3%, and revenue of $31.59K, 0% as expectations.
How did the market react to Vyome Holdings, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -3.03%, changed from $1.98 before the earnings release to $1.92 the day after.
When is Vyome Holdings, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Vyome Holdings, Inc. Common Stock's next earnings report?
Based on --
analysts, Vyome Holdings, Inc. Common Stock is expected to report EPS of -$0.19 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement